Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine Reduces Exacerbation Rate and Risk in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease
Related Posts
Chang E, Sie R, Mechure MG, Pak Y, Abbott R, Kuo T, Randle C, York J, Chang R, Jang AW, Cassano H, Mahajan AP, Hui[...]
Chen S, Fan Y, Su M, Lin Y, Zheng S, Zhou Z, Zhang W, Lin J, Hu S, Matucci-Cerinic M, Furst DE, Zhang G, Wang[...]
Dao KT, Singh S, Kaloty P, Bandak D, Yasonova M, Dhillon H, Singh C, Montana W. A Presumed Metastatic Lung Lesion Unveiling a Second Primary:[...]